{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:15:17Z","timestamp":1763018117803,"version":"3.37.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T00:00:00Z","timestamp":1578009600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T00:00:00Z","timestamp":1578009600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s10096-019-03794-7","type":"journal-article","created":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T07:03:20Z","timestamp":1578035000000},"page":"903-913","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Levels of evidence supporting clinical practice guidelines on invasive aspergillosis"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2000-6587","authenticated-orcid":false,"given":"Sof\u00eda","family":"Tejada","sequence":"first","affiliation":[]},{"given":"Laura","family":"Campogiani","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o","family":"Ferreira-Coimbra","sequence":"additional","affiliation":[]},{"given":"Stijn","family":"Blot","sequence":"additional","affiliation":[]},{"given":"Jordi","family":"Rello","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2020,1,3]]},"reference":[{"key":"3794_CR1","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3201\/eid2007.140087","volume":"20","author":"D Bitar","year":"2014","unstructured":"Bitar D, Lortholary O, Le Strat Y, Nicolau J, Coignard B, Tattevin P, Che D, Dromer F (2014) Population-based analysis of invasive fungal infections, France, 2001-2010. Emerg Infect Dis 20:1149\u20131155","journal-title":"Emerg Infect Dis"},{"key":"3794_CR2","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.idc.2015.10.015","volume":"30","author":"J Cadena","year":"2016","unstructured":"Cadena J, Thompson GR, Patterson TF (2016) Invasive aspergillosis: current strategies for diagnosis and management. Infect Dis Clin N Am 30:125\u2013142","journal-title":"Infect Dis Clin N Am"},{"key":"3794_CR3","doi-asserted-by":"publisher","unstructured":"Schmiedel Y, Zimmerli S (2016) Common invasive fungal diseases: an overview of invasive candidiasis, aspergillosis, cryptococcosis, and Pneumocystis pneumonia. Swiss Med Wkly. https:\/\/doi.org\/10.4414\/smw.2016.14281","DOI":"10.4414\/smw.2016.14281"},{"key":"3794_CR4","doi-asserted-by":"publisher","first-page":"ii27","DOI":"10.1093\/jac\/dkz041","volume":"74","author":"M Sanguinetti","year":"2019","unstructured":"Sanguinetti M, Posteraro B, Beigelman-Aubry C, Lamoth F, Dunet V, Slavin M, Richardson MD (2019) Diagnosis and treatment of invasive fungal infections: looking ahead. J Antimicrob Chemother 74:ii27\u2013ii37","journal-title":"J Antimicrob Chemother"},{"key":"3794_CR5","doi-asserted-by":"publisher","first-page":"e0204720","DOI":"10.1371\/journal.pone.0204720","volume":"13","author":"C Meyer","year":"2018","unstructured":"Meyer C, Bowers A, Wayant C, Checketts J, Scott J, Musuvathy S, Vassar M (2018) Scientific evidence underlying the American College of Gastroenterology\u2019s clinical practice guidelines. PLoS One 13:e0204720","journal-title":"PLoS One"},{"key":"3794_CR6","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1001\/jama.2009.205","volume":"301","author":"P Tricoci","year":"2009","unstructured":"Tricoci P, Allen JM, Kramer JM, Califf RM, Smith SC (2009) Scientific evidence underlying the ACC\/AHA clinical practice guidelines. JAMA 301:831\u2013841","journal-title":"JAMA"},{"key":"3794_CR7","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1086\/656735","volume":"51","author":"AR Khan","year":"2010","unstructured":"Khan AR, Khan S, Zimmerman V, Baddour LM, Tleyjeh IM (2010) Quality and strength of evidence of the Infectious Diseases Society of America clinical practice guidelines. Clin Infect Dis 51:1147\u20131156","journal-title":"Clin Infect Dis"},{"key":"3794_CR8","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/j.1398-9995.2009.01973.x","volume":"64","author":"JL Brozek","year":"2009","unstructured":"Brozek JL, Akl EA, Alonso-Coello P et al (2009) Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions. Allergy 64:669\u2013677","journal-title":"Allergy"},{"key":"3794_CR9","doi-asserted-by":"publisher","first-page":"123S","DOI":"10.1378\/chest.08-0654","volume":"133","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Cook DJ, Jaeschke R, Pauker SG, Sch\u00fcnemann HJ (2008) Grades of recommendation for antithrombotic agents: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 133:123S\u2013131S","journal-title":"Chest"},{"key":"3794_CR10","first-page":"1193","volume":"121","author":"Canadian Task Force on the Periodic Health Examination","year":"1979","unstructured":"Canadian Task Force on the Periodic Health Examination (1979) The Canadian guide to clinical preventive health care. Can Med Assoc J 121:1193\u20131254","journal-title":"Can Med Assoc J"},{"key":"3794_CR11","first-page":"18","volume":"171","author":"DH Lee","year":"2011","unstructured":"Lee DH, Vielemeyer O (2011) Analysis of overall level of evidence behind Infectious Diseases Society of America practice guidelines. Arch Intern Med 171:18\u201322","journal-title":"Arch Intern Med"},{"key":"3794_CR12","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jacc.2012.09.025","volume":"61","author":"AK Jacobs","year":"2013","unstructured":"Jacobs AK, Kushner FG, Ettinger SM et al (2013) ACCF\/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines. J Am Coll Cardiol 61:213\u2013265","journal-title":"J Am Coll Cardiol"},{"key":"3794_CR13","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.21037\/jtd.2019.06.56","volume":"11","author":"K Wan","year":"2019","unstructured":"Wan K, Liang H, Yan G, Zou B, Huang C, Jiang M (2019) A quality assessment of evidence-based guidelines for the prevention and management of ventilator-associated pneumonia: a systematic review. J Thorac Dis 11:2795\u20132807","journal-title":"J Thorac Dis"},{"key":"3794_CR14","doi-asserted-by":"crossref","unstructured":"Campogiani L, Tejada S, Ferreira-Coimbra J, Restrepo MI, Rello J (2019) Evidence supporting recommendations from international guidelines on treatment, diagnosis, and prevention of HAP and VAP in adults. Eur J Clin Microbiol Infect Dis","DOI":"10.1007\/s10096-019-03748-z"},{"key":"3794_CR15","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/cid\/ciw444","volume":"63","author":"TF Patterson","year":"2016","unstructured":"Patterson TF, Thompson GR, Denning DW et al (2016) Executive summary: practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis 63:433\u2013442","journal-title":"Clin Infect Dis"},{"key":"3794_CR16","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1086\/525258","volume":"46","author":"TJ Walsh","year":"2008","unstructured":"Walsh TJ, Anaissie EJ, Denning DW et al (2008) Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 46:327\u2013360","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"3794_CR17","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","volume":"24","author":"AJ Ullmann","year":"2018","unstructured":"Ullmann AJ, Aguado JM, Arikan-Akdagli S et al (2018) Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clin Microbiol Infect 24(Suppl 1):e1\u2013e38","journal-title":"Clin Microbiol Infect"},{"key":"3794_CR18","doi-asserted-by":"publisher","unstructured":"Garcia-Vidal C, Alastruey-Izquierdo A, Aguilar-Guisado M et al (2018) Executive summary of clinical practice guideline for the management of invasive diseases caused by Aspergillus: 2018 update by the GEMICOMED-SEIMC\/REIPI. Enferm Infecc Microbiol Clin. https:\/\/doi.org\/10.1016\/j.eimc.2018.03.018","DOI":"10.1016\/j.eimc.2018.03.018"},{"key":"3794_CR19","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.eimc.2011.01.010","volume":"29","author":"J Fort\u00fan","year":"2011","unstructured":"Fort\u00fan J, Carratal\u00e1 J, Gavald\u00e1 J et al (2011) Guidelines for the treatment of invasive fungal disease by Aspergillus spp. and other fungi issued by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2011 update. Enferm Infecc Microbiol Clin 29:435\u2013454","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"3794_CR20","doi-asserted-by":"crossref","unstructured":"Fanaroff AC, Califf RM, Windecker S, Smith SC, Lopes RD (2019) Levels of Evidence Supporting American College of Cardiology\/American Heart Association and European Society of Cardiology Guidelines, 2008-2018. JAMA 321:1069\u20131080","DOI":"10.1001\/jama.2019.1122"},{"key":"3794_CR21","doi-asserted-by":"crossref","unstructured":"Tissot F, Agrawal S, Pagano L, Petrikkos G, Groll AH, Skiada A, Lass-Fl\u00f6rl C, Calandra T, Viscoli C, Herbrecht R (2017) ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients. Haematologica 102:433\u2013444","DOI":"10.3324\/haematol.2016.152900"},{"key":"3794_CR22","doi-asserted-by":"crossref","unstructured":"De Pauw B, Walsh TJ, Donnelly JP, et al (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group. Clin Infect Dis 46:1813\u20131821","DOI":"10.1086\/588660"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-019-03794-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-019-03794-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-019-03794-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T00:35:09Z","timestamp":1609547709000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-019-03794-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,3]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["3794"],"URL":"https:\/\/doi.org\/10.1007\/s10096-019-03794-7","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"type":"print","value":"0934-9723"},{"type":"electronic","value":"1435-4373"}],"subject":[],"published":{"date-parts":[[2020,1,3]]},"assertion":[{"value":"25 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Rello has served as consultant and in the speakers\u2019 bureau for Pfizer and Astellas. Dr. Blot received research grants from Pfizer. The remaining authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}